Pharmacovigilance Data Validation: Biggest Surprises/Challenges With Safety Information

The Miraculous Revival: Navigating Safety Data Discrepancies in Safety Data

In the pharmaceutical industry, managing safety information is fraught with unexpected challenges. Conducting rigorous pharmacovigilance data validation is critical, and in our 21 years as a global provider of clinical and post marketing drug safety services, it’s safe to say we’ve witnessed our fair share of surprises.

Using our years of auditing experience in performing Good Clinical Practice (GCP compliance) and Good Pharmacovigilance Practice (GPV audit) reviews, as well as gap-fill analysis and pre-qualification assessments, our White Gloves Audit Group has compiled a collection of unexpected findings to help guide you away from common pitfalls:

Unexpected Challenges in Pharmacovigilance Data Validation: Incorrect Safety Entry

Adverse event data entry errors and clinical safety data anomalies often arise during routine data management:

• Patient Died and Recovered: Instances where patients are reported as deceased and later found to recorded as ‘recovered’ later within the report.
• Future Date of Onset for the Reaction: Reactions documented as having occurred at dates in the future, as opposed to in the past or before any medication has been given.
• Reaction Resolved in the Past: Contrastingly, cases found where adverse reactions are recorded as having resolved before they were reported to have started.
• 200-Year-Old Patient: Reports featuring patients with implausible ages, such as being over two centuries old, which warrant a place in the record books!
• Male Pregnancies: Yes, recorded in the safety database, a male pregnancy that went to term.

Safety Reporting Mitigation Strategies for Pharmacovigilance Data Validation

Understanding these pharmacovigilance audit findings allows safety teams to implement robust safety reporting mitigation strategies:

• Robust Data Validation: Implement comprehensive drug safety database validation processes to catch safety data discrepancies and correct anomalies before transmission.

• Advanced Training: Provide detailed training for staff on data entry and anomaly detection to prevent adverse event data entry errors at the source and ensure strong GCP compliance.

• Automated Alert Systems: Deploy automated data validation in pharmacovigilance with built-in alerts for detecting improbable data, such as extreme ages or future dates, to flag issues immediately.

• Regular Data Audits: Conduct periodic audits of safety data to systematically review pharmacovigilance audit findings and rectify discrepancies, maintaining a clear pharmacovigilance audit trail to enhance audit preparedness. This should be a core component of any Quality Management System (QMS) in pharmacovigilance.

• Clear Reporting Guidelines: The safety data may be correct, but what if it was not reported on time or to all of the Regulatory Agencies it should have been? There is a need to develop, maintain, and distribute clear adverse event reporting guidelines to accurately document adverse events, ensuring a consistent approach companywide.

Overcoming Regulatory Non-Compliance Risks

These safety reporting mitigation strategies are essential towards ensuring accuracy and reliability in safety reporting and preventing serious regulatory non-compliance risks during inspections, whilst also safeguarding against the potential legal, financial, and reputational consequences that are directly associated with non-compliance.

With over 75 years of senior auditor experience performing a GPV audit against multinational legislation requirements, the number of unexpected findings we still find during inspections underscores the importance for Companies to take on these proactive measures. Utilizing automated solutions—such as our proprietary R.A.P.T.A.R.® Reporting system—streamlines your automated data validation in pharmacovigilance to reduce errors while keeping your Quality Management System (QMS) in pharmacovigilance fully compliant.

Don't let unexpected findings compromise your integrity or increase regulatory non-compliance risks — schedule an introductory meeting today and let us guide your pharmacovigilance data validation processes.

Maintain a complete pharmacovigilance audit trail and adhere to clear adverse event reporting guidelines with PharSafer®. Explore our Pharmacovigilance Services and Regulatory Intelligence solutions, or Contact Us directly to achieve and maintain the highest standards of drug safety compliance.